CVRX Insider Trading Activity and SEC Form 4 Filings
CVRX insider trading summary
Over the past 12 months, insiders at CVRx, Inc. (CVRX) reported 20 sales worth $783K by 8 insiders and 3 open-market purchases worth $377K by 2 insiders on SEC Form 4. Net insider selling was $407K.
Latest CVRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 13, 2026 | Brent Binkowski | Chief Operating Officer | Buy | $76K (26,223 @ $2.91) |
| Aug 12, 2026 | Brent Binkowski | Chief Operating Officer | Sell | $3K (1,309 @ $2.55) |
| Mar 2, 2026 | Paul Verrastro | Chief Mktg & Strat Officer | Sell | $10K (1,284 @ $7.90) |
| Mar 2, 2026 | Philip B. Adamson | Chief Medical Officer | Sell | $10K (1,262 @ $7.90) |
| Mar 2, 2026 | Kevin Hykes | Pres & CEO | Sell | $61K (7,763 @ $7.90) |
| Mar 2, 2026 | Jared Oasheim | Chief Financial Officer | Sell | $14K (1,744 @ $7.90) |
| Mar 2, 2026 | Robert Allen John | Chief Revenue Officer | Sell | $31K (3,964 @ $7.90) |
| Feb 20, 2026 | Mudit K. Jain | Insider | Buy | $298K (46,800 @ $6.36) |
| Feb 18, 2026 | Mudit K. Jain | Insider | Buy | $3K (600 @ $4.64) |
| Nov 26, 2025 | Johnson & Johnson Innovation - JJDC, Inc. | Insider | Sell | $64K (6,337 @ $10.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.